MEDIPOST Secures FDA Agreement for CARTISTEM Phase III Strategy in US

MEDIPOST has secured FDA agreement to conduct a single pivotal Phase III study for CARTISTEM in the US, marking an impor...

June 10, 2026 | Wednesday | News
Pfizer Secures FDA Approval for Expanded Hympavzi Use in Hemophilia

Pfizer has received US FDA approval for an expanded indication of Hympavzi for hemophilia A or B, broadening its use to ...

June 10, 2026 | Wednesday | News
Lilly’s Oral GLP-1 Foundayo Shows Superior Phase III Diabetes Results

Eli Lilly has reported detailed Phase III results from three ACHIEVE trials evaluating Foundayo, or orforglipron, an ora...

June 9, 2026 | Tuesday | News
Argo Biopharma to Present Updated Phase II Data for siRNA HAE Therapy at EAACI 2026

Argo Biopharma will present updated Phase II results for BW-20805, its investigational siRNA therapy for hereditary angi...

June 9, 2026 | Tuesday | News
Otsuka Reports Phase III Data Showing VOYXACT Preserved Kidney Function in IgA Nephropathy

Otsuka has reported positive interim Phase III VISIONARY data showing that VOYXACT preserved kidney function over 12 mon...

June 8, 2026 | Monday | News
Hansa Biopharma Reports Positive European Post-Authorisation Data for Idefirix

Hansa Biopharma has reported positive topline results from a European post-authorisation efficacy study of Idefirix in h...

June 8, 2026 | Monday | News
SGS Acquires CMIC to Expand North American Bioanalytical Testing Capabilities

SGS has acquired CMIC, INC., a specialised bioanalytical testing services provider based in Chicago, Illinois, strengthe...

June 5, 2026 | Friday | News
FDA Approves TREMFYA Label Expansion for Structural Joint Damage in Psoriatic Arthritis

Johnson & Johnson has received US FDA approval for a supplemental Biologics License Application to include evidence ...

June 5, 2026 | Friday | News
Omnix Medical Announces First Patients Dosed in Phase II Trial of Antimicrobial Lead Compound OMN6

Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...

June 4, 2026 | Thursday | News
CellProthera Prepares For Phase 3 Push As Regenerative Cardiology Moves Closer To Clinical Reality

Regenerative medicine is steadily redefining the future of cardiovascular care, with cell based therapies moving beyond ...

June 1, 2026 | Monday | News
PREMIA and Lind expand AI-powered clinical trial screening across Asia-Pacific

Japanese startup Precision Medicine Asia (PREMIA) and US-based Lind have announced the formation of ...

May 29, 2026 | Friday | News
SUANNUTRA USA Secures US Distribution Rights for TetraSOD

Nutraceutical ingredients innovator SUANNUTRA USA has inked a distribution agreement with Spanish biotech company Fitopl...

May 20, 2026 | Wednesday | News
Asia-Pacific Healthcare Systems Face Growing Pressure to Modernise Digital Infrastructure

Healthcare systems across Asia-Pacific are entering a new phase of digital transformation, as hospitals face rising pres...

May 12, 2026 | Tuesday | Opinion
Expecto Health Science Partners with Neuratrial to Pioneer AI-Driven CRO Operating Model

Expecto Health Science, a full-service Asia-Pacific Contract Research Organization (CRO),  announced a strategic pa...

April 8, 2026 | Wednesday | News
Singapore Strengthens Its Position As A Trusted Hub For Global Biopharmaceutical Manufacturing

On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...

March 13, 2026 | Friday | News
GCCL and Medicover announce strategic collaboration to strengthen multinational clinical trial services

South Korea-based GCCL Co., a data-driven clinical trial services provider, and Germany-based Medicover Integrated Clini...

February 11, 2026 | Wednesday | News
Korea's GCCL partners with OPIS to advance global clinical trial capabilities

GCCL, a leading South Korea-based provider of clinical trial sample analysis, and US-based OPIS, a global full-service c...

January 16, 2026 | Friday | News
Curie Oncology and Oncoshot deploy AI-powered clinical research tools

Curie Oncology, one of Southeast Asia's fastest-growing private oncology networks, has partnered with Singapore-based he...

December 17, 2025 | Wednesday | News
Zuellig Pharma opens state-of-the-art clinical trial support innovation centre in South Korea

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced the grand opening of its new state-of-the-...

December 1, 2025 | Monday | News
NEXT Oncology expands to Japan in partnership with Kansai Medical University

NEXT Oncology, an Avacare business, has expanded its services to Asia through a strategic partnership with Kansai Medica...

November 6, 2025 | Thursday | News
Eli Lilly Commits Over $1.2 Billion to Expand Puerto Rico Manufacturing Hub

The project will modernize Lilly’s facilities in Carolina, generate over 1,100 new jobs across construction and op...

October 29, 2025 | Wednesday | News
Singapore's Raffles Medical Group partners with Gene Solutions to expand access to global cancer clinical trials

Singapore-based Raffles Medical Group and Gene Solutions, headquartered in Vietnam, have signed a Memorandum of Understa...

October 28, 2025 | Tuesday | News
Avance Clinical opens CoE to accelerate early phase biotech trials

Avance Clinical, the Australia-based global CRO partner for biotechs, has announced the launch of its dedicated Early Ph...

October 23, 2025 | Thursday | News
AI Meets CRO: Expecto Health Science Partners with VertisPro to Overcome Patient Recruitment Challenges

Expecto Health Science, an emerging Asia-Pacific Contract Research Organisation (CRO) led by a highly experienced leader...

August 25, 2025 | Monday | News
Australian clinical trials accelerate innovation by empowering digital unified platform approach

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industr...

July 10, 2025 | Thursday | News